Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_assertion type Assertion NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_head.
- NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_assertion description "[The genes E-cadherin (ECAD), transmembrane protein with epidermal growth factor-like and 2 follistatin-like domains 2 (TMEFF2), retinoic acid receptor beta (RAR?), and O-6 methylguanine DNA methyltransferase (MGMT) had high sensitivity (>75%) and specificity for the detection of oral cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_provenance.
- NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_assertion evidence source_evidence_literature NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_provenance.
- NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_assertion SIO_000772 22252571 NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_provenance.
- NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_assertion wasDerivedFrom befree-20140225 NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_provenance.
- NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_assertion wasGeneratedBy ECO_0000203 NP748522.RADHII_mIKoJbesqlkX_AH5MR4lVgNsNzyfWtgjx2stBs130_provenance.